There were 92 patients in the transfer cohort (age 65±13 years; 38% female; 74% white; 74% ischemic). Control cohort (75% white; 76% ischemic) had similar NIHSS as transfer cohort. For the transfer cohort, median length of stay at IRF was 9 (IQR 4-13) days. Most common indications for transfer were neurological (31%) and cardiovascular (28%). Compared to control, the transfer cohort had statistically higher rates of comorbid medical conditions (A fib, heart, renal, respiratory disease, and metabolic diseases), lower mean Functional Independence Measure (FIM) score on admission (52±19 vs 64±18; p=0.001), and higher rate of prescribed sedatives/hypnotics (82% vs. 23%; p<0.001) during their IRF stay. Only 43% of the transfer cohort returned to IRF, 18% died and the rest discharged elsewhere.